Investment Thesis for Aldeyra Therapeutics, Inc. (NASDAQ: ALDX)

Abstract

This working paper is an in-depth analysis Aldeyra Therapeutics, Inc. Our analysis examines the factors that impact ALDX’s underlying business. This economic analysis is then combined with our unique net present value (NPV) model to determine ALDX’s financial position. The NPV model will be presented along-side Monte-Carlo simulations to reveal the distribution of probable free cash flows and the likelihood of future earnings. We also studied the proxy report to examine the compensation practices of ALDX and determine whether they are well-aligned with shareholder interests. Our objective is for readers to understand ALDX’s business plan and financial standing to construct a sound investment decision.